Research Catalog

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary

Title
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
Publication
Washington, D.C. : National Academies Press, [2009], ©2009.

Available Online

http://search.nap.edu/nap-cgi/de.cgi?term=0309120888

Items in the Library & Off-site

Filter by

1 Item

StatusFormatAccessCall NumberItem Location
TextRequest in advance RA401.A3 B74 2009gOff-site

Details

Additional Authors
  • Wizemann, Theresa M.
  • Robinson, Sally.
  • Giffin, Robert.
  • Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Description
xviii, 132 pages : illustrations; 23 cm
Summary
"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development".
Subjects
Bibliography (note)
  • Include bibliographical references (p. 104-105).
Additional Formats (note)
  • Also available online.
Contents
Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary.
ISBN
  • 0309120888
  • 9780309120883
OCLC
  • ocn317114592
  • 317114592
  • SCSB-5462450
Owning Institutions
Columbia University Libraries